Draft Evidence Report
Midwest CEPAC

PDF cover

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Prostate Cancer: Draft Evidence Report

ICER’s Draft Evidence Report on treatments for high risk prostate cancer, open to public comment until August 9, 2018. For more information on submitting a public comment, please visit our stakeholder engagement page.


View All Materials on this Topic or Go Back to View More Materials